Ghent University Academic Bibliography

Journal Article
A1
open access

Efficacy and safety of risankizumab for active psoriatic arthritis : 196-week results from the KEEPsAKE 1 and KEEPsAKE 2 randomized clinical trials

Andrew Ostor, Filip Van den Bosch (UGent) , Kim Papp, Mauro Keiserman, Ricardo Blanco, Angela Crowley, Douglas White, Ana Biljan, Tshepiso Madihlaba, Kyle Carter, et al.

(2025) RHEUMATOLOGY AND THERAPY. 12(6). p.1103-1123

Add to list

Journal Article
A1
open access

Characterizing the cell-free transcriptome in a humanized diffuse large B-cell lymphoma patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Philippe Decruyenaere (UGent) , Willem Daneels (UGent) , Annelien Morlion (UGent) , Kimberly Verniers (UGent) , Jasper Anckaert (UGent) , Jan Tavernier (UGent) , Fritz Offner (UGent) and Jo Vandesompele (UGent)

(2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(18).

Add to list

Journal Article
A1
open access

Adjusting for time-varying treatment switches in randomized clinical trials : the danger of extrapolation and how to address it

Hege Michiels, An Vandebosch (UGent) and Stijn Vansteelandt (UGent)

(2024) STATISTICS IN BIOPHARMACEUTICAL RESEARCH. 17(1). p.54-66

Add to list

Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma

Thomas Look, Emanuele Puca, Marcel Bühler (UGent) , Daniel Kirschenbaum, Roberto De Luca, Riccardo Stucchi, Domenico Ravazza, Cesare Di Nitto, Patrick Roth, Yonatan Katzenelenbogen, et al.

(2023) SCIENCE TRANSLATIONAL MEDICINE. 15(697).

Add to list

Journal Article
A1
open access

Real-life effectiveness of apremilast for the treatment of psoriasis in Belgium : results from the observational OTELO study

Pierre-Dominique Ghislain, Jo Lambert (UGent) , Xuãn-Lan Lam Hoai, Tom Hillary, Pierre-Paul Roquet-Gravy, Michel de la Brassinne and Siegfried Segaert

(2022) ADVANCES IN THERAPY. 39(2). p.1068-1080

Add to list

Health-related quality of life in patients with advanced prostate cancer : a systematic review

Alexander Kretschmer, Guillaume Ploussard, Isabel Heidegger, Igor Tsaur, Hendrik Borgmann, Cristian Surcel, Romain Mathieu, Pieter De Visschere (UGent) , Massimo Valerio, Roderick C.N. van den Bergh, et al.

(2021) EUROPEAN UROLOGY FOCUS. 7(4). p.742-751

Add to list

Journal Article
A1
open access

From science to success? Targeting tyrosine kinase 2 in spondyloarthritis and related chronic inflammatory diseases

Dominika Hromadova, Dirk Elewaut (UGent) , Robert D. Inman, Birgit Strobl and Eric Gracey (UGent)

(2021) FRONTIERS IN GENETICS. 12.

Add to list

Journal Article
A1
open access

Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials

Matthias Augustin, Jo Lambert (UGent) , Carla Zema, Elizabeth H. Z. Thompson, Min Yang, Eric Q. Wu, Viviana Garcia-Horton, Ziqian Geng, Joaquin M. Valdes, Avani Joshi, et al.

(2020) JAMA DERMATOLOGY. 156(12). p.1344-1353

Add to list

Journal Article
A1
open access

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update

Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G. McGonagle, Daniel Aletaha, Andra Balanescu, et al.

(2020) ANNALS OF THE RHEUMATIC DISEASES. 79(6). p.700-712

Add to list

ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer

Cecile Le Pechoux, Corinne Faivre-Finn, Sara Ramella, Fiona McDonald, Farkhad Manapov, Paul Martin Putora, Ben Slotman, Dirk De Ruysscher, Umberto Ricardi, Xavier Geets, et al.

(2020) RADIOTHERAPY AND ONCOLOGY. 152. p.89-95

Academic Bibliography

Efficacy and safety of risankizumab for active psoriatic arthritis : 196-week results from the KEEPsAKE 1 and KEEPsAKE 2 randomized clinical trials

Characterizing the cell-free transcriptome in a humanized diffuse large B-cell lymphoma patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Adjusting for time-varying treatment switches in randomized clinical trials : the danger of extrapolation and how to address it

Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma

Real-life effectiveness of apremilast for the treatment of psoriasis in Belgium : results from the observational OTELO study

Health-related quality of life in patients with advanced prostate cancer : a systematic review

From science to success? Targeting tyrosine kinase 2 in spondyloarthritis and related chronic inflammatory diseases

Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update

ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer

Contents

Support

Contact